Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Raises Target Price to $12

Futu NewsDec 16, 2024 21:31 · Ratings

Analysts' Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Keros Therapeutics (KROS)

TipRanksDec 16, 2024 20:50 · Ratings

Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?

Zacks Dec 9, 2024 22:15

Positive Outlook for Aldeyra Therapeutics: Buy Rating Backed by Promising Reproxalap Prospects and Strategic Partnership With AbbVie

TipRanksDec 9, 2024 19:32 · Ratings

Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference

Aldeyra TherapeuticsDec 2, 2024 13:00

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap

Zacks Nov 19, 2024 22:35